Evidence map›Paper›PMID 42294054›Full record

Trial reportFrontiers in digital health2026

Use of WeChat-based patient-doctor interaction improves patient experience of

Boshen Lin, Wenlin Zhang, Jinghui Zhang, Minjuan Lin, Jing Liu, Zhongxue Han, Yuming Ding, Qingzhou Kong, Miao Duan, Yueyue Li and 2 more

Registry-linked trialAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04850209 (The Impact of Interactive Patient Education Based on WeChat Group on the Eradication Rate of Helicobacter Pylori), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04850209 nacompletednot on this map

The Impact of Interactive Patient Education Based on WeChat Group on the Eradication Rate of Helicobacter Pylori

TypeinterventionalSponsorShandong UniversityRan2021 to 2022Enrolled438ConditionsHelicobacter Pylori Infection, Helicobacter Pylori Eradication, Patient EducationArmsoral and written education, Wechat group
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Boshen LinDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wenlin ZhangDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Jinghui ZhangDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Minjuan LinDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Jing LiuDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Zhongxue HanDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Yuming DingDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Qingzhou KongDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Miao DuanDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Yueyue LiDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Xiuli ZuoDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Yanqing LiDepartment of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: In this prospective, open-label randomized controlled trial, treatment-naïve Results: In total, 438 patients were enrolled for randomization. The WPDI group achieved eradication rates of 90.4% (198/219), 93.4% (198/212), and 94.2% (194/206), as evaluated by intention-to-treat, modified intention-to-treat, and per-protocol analysis, respectively. The eradication rates were comparable to those in the control group (89.5% [196/219], 93.3% [196/210], and 94.6% [192/203]. The assessment results of patient experience showed that more patients voted that the treatment was satisfactory or very satisfactory in the WPDI group (90.3% vs. 74.9%; Conclusions: The WeChat-based patient-doctor interaction improved patient experience of Clinical Trial Registration: ClinicalTrials.gov ID: NCT04850209.

Indexed as

helicobacter pyloripatient-doctor interactionpatient experiencetelemedicinetherapy

Identifiers

PMID42294054
PMCPMC13260394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.